Publication date: 10 November 2026 Source: Blood Advances, Volume 10, Issue 21 Author(s): Xi Yang, Henry Dumke, Swetha Thiruvengadam, Christine Argao, Joseph G. Schroers-Martin, Sree Lanka, Yazeed Sawalha, Hanan A. Alharthy, Sairah Ahmed, Izel Okcu, Grzegorz S. Nowakowski, Peter G. Doukas, Reem Karmali, Krithika Shanmugasundaram, Meryl Colton, Michael A. Spinner, Stefania Marron Rodriguez, Adam S. DuVall, Brock G. Lakin, Christopher R. D’Angelo
Second-line CD19 CAR T vs platinum salvage and autologous stem cell transplant for primary mediastinal B-cell lymphoma. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S2473952926005951?dgcid=rss_sd_all
Second-line CD19 CAR T vs platinum salvage and autologous stem cell transplant for primary mediastinal B-cell lymphoma. Blood Advances. https://www.sciencedirect.com/science/article/pii/S2473952926005951?dgcid=rss_sd_all
“Second-line CD19 CAR T vs platinum salvage and autologous stem cell transplant for primary mediastinal B-cell lymphoma.” Blood Advances.
@article{article93340,
title = {Second-line CD19 CAR T vs platinum salvage and autologous stem cell transplant for primary mediastinal B-cell lymphoma},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S2473952926005951?dgcid=rss_sd_all}
}